Related Experiment Video
Updated: Apr 7, 2026
09:11
Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma
Published on: May 24, 2024
1.5K
Primary hepatic neuroendocrine carcinoma
Jong Man Kim1, Se Yeong Kim1, Choon Hyuck David Kwon1
1Department of Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
Korean Journal of Hepato-Biliary-Pancreatic Surgery
|July 9, 2015
Summary
A rare primary neuroendocrine carcinoma in the liver was diagnosed in a 67-year-old woman. Surgical resection was successful, with no recurrence observed three months post-operation.
Area of Science:
- Hepatobiliary surgery
- Surgical oncology
- Neuroendocrine tumors
Background:
- A 67-year-old female patient presented with a suspected liver tumor.
- Previous fine needle aspiration diagnosed adenocarcinoma.
- Imaging revealed a large 9 cm tumor in hepatic segments 4, 5, and 8.
Observation:
- Preoperative diagnosis was primary liver cancer, suspected intrahepatic cholangiocarcinoma.
- A central hepatectomy was performed for tumor removal.
- Immunohistochemical analysis of the resected specimen was crucial for diagnosis.
Findings:
- The liver tumor was definitively diagnosed as a primary neuroendocrine carcinoma.
- The patient has remained recurrence-free for 3 months following the hepatectomy.
Implications:
- This case highlights the importance of immunohistochemistry in diagnosing rare liver malignancies.
- Successful surgical management of primary liver neuroendocrine carcinoma is feasible.
- Further research into the characteristics and treatment of primary liver neuroendocrine tumors is warranted.
